PETRI DISH PERSPECTIVES
PETRI DISH PERSPECTIVES
Manead Khin
Episode 71: Fate of Pharma M&A
22 minutes Posted Sep 3, 2026 at 10:00 am.
Is Big Pharma Still an Innovation Industry or an Acquisition Industry?
How Pharma Became a Consolidation Machine and Why It Can't Stop?
From Megamergers to the "String of Pearls" and the Rise of Licensing
The Deals That Worked and the Deals That Didn't
China Changes the Equation
The Geopolitical Contradiction
Does M&A Actually Help Innovation?
Scarcity, Convergence, and the Pipeline Problem
What the Future of Pharma Dealmaking Actually Looks Like?
0:00
22:24
Download MP3
Show notes
Send us Fan Mail In this episode of Petri Dish Perspectives, we take a step back from individual companies to examine one of the most powerful forces shaping the pharmaceutical industry: M&A, licensing, and the global competition for innovation. We explore how today's pharmaceutical giants were built through decades of consolidation, from Pfizer, GlaxoSmithKline, and Novartis to some of the industry's biggest modern transactions and why dealmaking has increasingly become essential for com...